A prospective, multicenter cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has validated an ...

My best advice for anyone recently diagnosed with MBC is to keep a notebook and take someone with you to every appointment.

Adding tucatinib (Tukysa) to first-line maintenance therapy with trastuzumab (Herceptin) and pertuzumab (Perjeta) delayed ...

If your cancer has come back, your doctor might suggest a biopsy to verify that it’s a recurrence instead of a second cancer.

Patients with hormone receptor (HR)-positive, HER2-negative advanced breast cancers had similar progression-free survival (PFS) whether they were treated with sacituzumab govitecan-hziy (Trodelvy) or ...

Producing the highest accuracy, the 9-gene set produced became the basis of the final classifier. When applied to multiple ...

Learn about prostate cancer symptoms, diagnosis, staging and the latest treatments including robotic surgery, SBRT, radioligand therapy and targeted drugs.

In this meta-analysis, researchers evaluated the use and/or prolongation of ADT in men with non-metastatic prostate cancer undergoing definitive radiotherapy. For men with prostate cancer treated with ...